2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Glioblastoma
4
Glioma
3
Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Astrocytoma
2
Whooping Cough
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplasms, Plasma Cell
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Measles
1
Lymphoma, Non-Hodgkin
1
Lipodystrophy, Congenital Generalized
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Human Papillomavirus-Related Cervical Carcinoma
1
Hodgkin Disease
1
Hepatitis B
1
Interventions
Imatinib Mesylate
142
nilotinib
94
Cyclophosphamide
91
fludarabine phosphate
75
fludarabine
67
Dasatinib
63
Mycophenolic Acid
60
Whole-Body Irradiation
59
Tacrolimus
47
Busulfan
45
Cyclosporine
36
Peripheral Blood Stem Cell Transplantation
35
Cytarabine
35
Melphalan
30
bosutinib
27
ponatinib
26
Granulocyte Colony-Stimulating Factor
26
thymoglobulin
25
Thiotepa
25
Methotrexate
25
Filgrastim
25
asciminib
24
Antilymphocyte Serum
24
Stem Cell Transplantation
22
Sirolimus
17
Interferon-alpha
16
sargramostim
15
Cord Blood Stem Cell Transplantation
14
Clofarabine
13
Bone Marrow Transplantation
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts